Cesar Oniangue Ndza
About Cesar Oniangue Ndza
Cesar Oniangue Ndza is a Senior Manager in Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) at Bristol Myers Squibb in Zürich, Switzerland. He has extensive experience in virology, oncology, and health economics, with a strong academic background and a history of research and advisory roles.
Current Role at Bristol Myers Squibb
Cesar Oniangue Ndza currently holds the position of Senior Manager in Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) at Bristol Myers Squibb. Based in the Zürich area of Switzerland, he plays a crucial role in applying economic evaluation techniques and real-world data to inform healthcare decisions. His work supports the development of innovative healthcare solutions by providing insights into the economic impact and real-world effectiveness of medical products and treatments.
Previous Roles at Bristol Myers Squibb
Throughout his tenure at Bristol Myers Squibb, Cesar Oniangue Ndza has held various positions. He was the Brand Access Manager/ RWE and HEOR Lead for eight months in 2017-2018, focusing on market access strategies. From 2016 to 2017, he served as a Scientific Advisor Oncology, Gastrointestinal Cancers Lead, and also as a Scientific Advisor Hemato-Oncology and Virology for five months in 2016. His first role at Bristol Myers Squibb was as a Project Manager Virology from 2011 to 2012, where he managed virology-related projects.
Academic Background
Cesar Oniangue Ndza possesses a strong academic background in health economics and virology. He earned a Master of Science (MSc) in Economic Evaluation for Health Technology Assessment from the University of York, along with a Postgraduate Diploma and Certificate in Health Economics. He also achieved a PhD in Virology from the University of Duisburg-Essen. His earlier education includes a Master's degree and a Postgraduate Certificate in Human Biology with specialization in Bacteriology and Virology from Université Felix Houphouet-Boigny, as well as a Bachelor's degree in Biochemistry with a specialization in Applied and Industrial Microbiology. Additionally, he holds a Certificate in Statistical Design and Analysis of Experiments from MIT.
Research and Academic Positions
Before joining Bristol Myers Squibb, Cesar Oniangue Ndza was actively involved in research. He worked as a Doctoral Research Scientist at the University of Duisburg-Essen from 2003 to 2007, where he focused on virology research. Following that, he conducted postdoctoral research at the Ragon Institute of MGH, MIT, and Harvard in the Greater Boston Area, concentrating on immunology and virology. Earlier in his career, he served as a Research Assistant at the Laboratory of Microbiology, Institute Pasteur of Ivory Coast, contributing to microbiology research from 2000 to 2002.
Expertise in Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE)
Cesar Oniangue Ndza has extensive experience in Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE). His expertise spans various roles, including his current position as Senior Manager HEOR and RWE at Bristol Myers Squibb. He has played pivotal roles in market access strategies, oncology research, and virology projects. His background in both academic and applied research equips him with the skills necessary to leverage economic evaluation and real-world data in healthcare decision-making.